Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Transgenic antibody production agreement signed by Genzyme Transgenics and Abgenix

May 5, 2000

Gliatech submits ADCON-P preclinical module to FDA

May 4, 2000

Dapsone topical gel progresses through the pipeline for acne and itch

April 28, 2000

Successful application of antedrug approach to the development of topical antiinflammatory agents

April 27, 2000

Abbott and Chrysalis BioTechnology collaborate on Chrysalin development

April 26, 2000

Faulding obtains Australian rights to ConXn

April 19, 2000

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New compounds from Japanese lab inhibit Th2-type cytokine production

April 7, 2000

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Chemokine receptor modulators in early development at AstraZeneca

April 5, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...